Tailor-made solutions for the healthcare industry
Visit B. Braun OEM at ICSE 2015. Themed by “We are with you right from the start“ we will walk you through our service portfolio from offering products for your clinical trial to successful market launch of your product.
Visit B. Braun OEM at ICSE 2015. Themed by “We are with you right from the start“ we will walk you through our service portfolio from offering products for your clinical trial to successful market launch of your product.
B. Braun OEM Division. Tailor-made solutions for the healthcare industryExpertise in contract manufacturing and infusion therapy products
B. Braun supplies healthcare markets worldwide and is employing approx. 54,000 individuals.
The company is currently represented in more than 62 countries worldwide and the portfolio comprises more than 120,000 pharmaceutical and medical articles.
B. Braun OEM offers standard products or customized versions. Even the standard range contains hundreds of product versions, with which countless applications can be implemented.
Standard products
- Infusion and injection solutions
- Medical devices for drug admixture
- Automated infusion pumps
- Products for venipuncture and injection
- Products for infection prevention
OEM is specialized in developing customer-specific solutions for you. Most of our products can be individually adapted to your requirements.
Customized products and services
- Contract manufacturing
- Product development and private labeling
- Product combination
We look forward to meeting you at our booth 1D21!
B. Braun Melsungen AG
OEM Division Europe
Carl-Braun-Strasse 1
34212 Melsungen
Germany
Phone: +49 5661 71-0
Fax: +49 5661 71-3562
info-europe@bbraunoem.com
http://www.bbraunoem.comwww.kitpacking-bbraun.com
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
